ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 103 filers reported holding ALBIREO PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $243,762 | +10.3% | 11,280 | -1.2% | 0.00% | – |
| Q3 2022 | $221,000 | -1.8% | 11,416 | +0.7% | 0.00% | – |
| Q2 2022 | $225,000 | -30.6% | 11,335 | +4.5% | 0.00% | – |
| Q1 2022 | $324,000 | +37.9% | 10,846 | +7.3% | 0.00% | – |
| Q4 2021 | $235,000 | -19.0% | 10,112 | +9.0% | 0.00% | – |
| Q3 2021 | $290,000 | -10.5% | 9,279 | +0.9% | 0.00% | – |
| Q2 2021 | $324,000 | -23.6% | 9,200 | -23.5% | 0.00% | – |
| Q1 2021 | $424,000 | -40.4% | 12,028 | -36.5% | 0.00% | – |
| Q4 2020 | $711,000 | +214.6% | 18,929 | +172.8% | 0.00% | – |
| Q1 2018 | $226,000 | – | 6,939 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 270,146 | $6,627,000 | 3.42% |
| Perceptive Advisors | 1,704,330 | $39,506,000 | 1.50% |
| Birchview Capital, LP | 38,000 | $932,000 | 0.88% |
| SECTORAL ASSET MANAGEMENT INC | 229,978 | $5,641,000 | 0.77% |
| BVF INC/IL | 200,500 | $4,918,000 | 0.64% |
| Artal Group S.A. | 500,000 | $12,265,000 | 0.45% |
| PA Capital LLC | 14,692 | $360,000 | 0.38% |
| Chicago Capital, LLC | 180,911 | $4,438,000 | 0.36% |
| TPG Group Holdings (SBS) Advisors, Inc. | 716,381 | $17,573,000 | 0.28% |
| Fosun International Ltd | 197,005 | $4,492,000 | 0.27% |